Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.21	10.81	9.24	27.38	5.54
Short-Term Investments	40.12	91.38	159.64	158.84	17.3
Cash & Short-Term Investments	47.32	102.19	168.89	186.22	22.84
Cash Growth	-53.69%	-39.49%	-9.31%	715.39%	-34.42%
Other Receivables	0.81	0.6	-	-	-
Receivables	0.81	0.6	-	-	-
Prepaid Expenses	1.84	2.74	3.86	2.94	2.52
Restricted Cash	0.78	-	-	-	-
Other Current Assets	0.06	0.18	-	-	-
Total Current Assets	50.81	105.71	172.75	189.16	25.36
Property, Plant & Equipment	24.9	24.08	28.53	30.6	16.35
Long-Term Investments	22.88	26.41	23.94	85.35	-
Long-Term Deferred Charges	0.05	0.37	-	-	2.36
Other Long-Term Assets	0.99	3.22	2.59	2.61	2.47
Total Assets	99.63	159.78	227.81	307.72	46.54
Accounts Payable	1.51	2.99	3.59	3.57	1.6
Accrued Expenses	8.34	12.49	15.14	12.38	6.66
Current Portion of Leases	2.25	2.78	2.39	2.5	1.5
Current Unearned Revenue	3.02	2.2	1.99	2.87	1.5
Other Current Liabilities	0.74	-	-	-	-
Total Current Liabilities	15.86	20.46	23.12	21.33	11.26
Long-Term Leases	22.96	17.44	20.22	21.85	9.38
Long-Term Unearned Revenue	3.62	9.11	12.92	14.21	-
Other Long-Term Liabilities	-	0.04	0.04	0.21	0.33
Total Liabilities	42.43	47.04	56.3	57.6	20.97
Additional Paid-In Capital	484.5	476.99	467.51	457.43	3.45
Retained Earnings	-427.4	-364.29	-295.09	-206.99	-108.4
Comprehensive Income & Other	0.1	0.04	-0.92	-0.32	-
Total Common Equity	57.2	112.74	171.51	250.12	-104.95
Shareholders' Equity	57.2	112.74	171.51	250.12	25.57
Total Liabilities & Equity	99.63	159.78	227.81	307.72	46.54
Total Debt	25.21	20.22	22.61	24.36	10.88
Net Cash (Debt)	22.11	81.97	146.28	161.86	11.96
Net Cash Growth	-73.02%	-43.96%	-9.63%	1253.27%	-51.46%
Net Cash Per Share	0.58	2.17	3.92	4.88	5.69
Filing Date Shares Outstanding	38.34	38.13	37.81	37.47	36.33
Total Common Shares Outstanding	38.34	38.11	37.8	37.4	2.13
Working Capital	34.96	85.25	149.63	167.83	14.1
Book Value Per Share	1.49	2.96	4.54	6.69	-49.27
Tangible Book Value	57.2	112.74	171.51	250.12	-104.95
Tangible Book Value Per Share	1.49	2.96	4.54	6.69	-49.27
Machinery	10.13	10.42	10.1	8.26	5.32
Leasehold Improvements	0.29	0.29	0.27	0.15	-

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q